Main > EAR NOSE THROAT (ENT) > Tumor Necrosis Factor AntAgonist > MAb Type TNF AntAgonist. > Etanercept; InflixiMAb Etc. > Immune Cochlear Vestibular Disorde > Patent. > Claims > Claim 1: Immune Ear Disorder Treat > Adm. TNF AntAgonist. Claim 3:
Adm. TNF AntAgonist. Claim 3:'s subsections
Immune CochlearVestibular Disorder
Adm. TNF AntAgonist. Claim 3:'s products
This section has no products